bpc 157 glp 1 PMOS and Peptide Therapy: What the 2026 Evidence Says About GLP-1, Kisspeptin, and BPC-157 Semaglutide 5mg — Selective GLP-1
Description
Pernicious anemia can also lead to a variety of symptoms, including fatigue, weakness, and neurological problems, as vitamin B12 is necessary for the proper functioning of the nervous system
doi: 10.1038/nm.2150 124 KerkhoffCSorgCTandonNNNackenW
This suggests that GLP-1 receptor activation alone may not substantially increase deficiency risk
My two cents is putting these on category 1 does not give fda approval from a drug standpoint
